Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Buckley

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 31, 2015
Traumatic brain injury and bipolar psychosis in the Genomic Psychiatry CohortKristina Cieslak, Michelle Pato, Peter Buckley, et al.
Psychiatric Services (Washington, D.C.)|October 5, 2002
Insight into illness and attitudes toward medications among inpatients with schizophreniaMartha Sajatovic, Debra S Rosch, Harry J Sivec, et al.
Psychiatry Research|November 10, 2009
Defining "good" and "poor" outcomes in patients with schizophrenia or schizoaffective disorder: a multidimensional data-driven approachIlya A Lipkovich, Walter Deberdt, John G Csernansky, et al.
Schizophrenia Research|May 16, 2019
Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophreniaCynthia Shannon Weickert, Cynthia H Lee, Rhoshel K Lenroot, et al.
Plos One|July 30, 2013
Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychoticsJoseph McEvoy, Rebecca A Baillie, Hongjie Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2007
Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonistsDramane I Lainé, Haibo Xie, Noémie Buffet, et al.
Schizophrenia Research|July 17, 2017
Early trauma and clinical features of schizophrenia cases influenced by the BDNF Val66Met alleleAndré B Veras, Clayton Peixoto, Julie Walsh Messinger, et al.
Journal of Psychopharmacology (Oxford, England)|December 17, 2009
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trialsJohn M Kane, Thomas R E Barnes, Christoph U Correll, et al.
Journal of Clinical Psychopharmacology|June 19, 2013
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS studyDonald C Goff, Joseph P McEvoy, Leslie Citrome, et al.
Molecular Psychiatry|February 19, 2020
GWAS significance thresholds for deep phenotyping studies can depend upon minor allele frequencies and sample sizeHuma Asif, Ney Alliey-Rodriguez, Sarah Keedy, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 31, 2015
Traumatic brain injury and bipolar psychosis in the Genomic Psychiatry CohortKristina Cieslak, Michelle Pato, Peter Buckley, et al.
Psychiatric Services (Washington, D.C.)|October 5, 2002
Insight into illness and attitudes toward medications among inpatients with schizophreniaMartha Sajatovic, Debra S Rosch, Harry J Sivec, et al.
Psychiatry Research|November 10, 2009
Defining "good" and "poor" outcomes in patients with schizophrenia or schizoaffective disorder: a multidimensional data-driven approachIlya A Lipkovich, Walter Deberdt, John G Csernansky, et al.
Schizophrenia Research|May 16, 2019
Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophreniaCynthia Shannon Weickert, Cynthia H Lee, Rhoshel K Lenroot, et al.
Plos One|July 30, 2013
Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychoticsJoseph McEvoy, Rebecca A Baillie, Hongjie Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2007
Discovery of novel 8-azoniabicyclo[3.2.1]octane carbamates as muscarinic acetylcholine receptor antagonistsDramane I Lainé, Haibo Xie, Noémie Buffet, et al.
Schizophrenia Research|July 17, 2017
Early trauma and clinical features of schizophrenia cases influenced by the BDNF Val66Met alleleAndré B Veras, Clayton Peixoto, Julie Walsh Messinger, et al.
Journal of Psychopharmacology (Oxford, England)|December 17, 2009
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trialsJohn M Kane, Thomas R E Barnes, Christoph U Correll, et al.
Journal of Clinical Psychopharmacology|June 19, 2013
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS studyDonald C Goff, Joseph P McEvoy, Leslie Citrome, et al.
Molecular Psychiatry|February 19, 2020
GWAS significance thresholds for deep phenotyping studies can depend upon minor allele frequencies and sample sizeHuma Asif, Ney Alliey-Rodriguez, Sarah Keedy, et al.
Pageof 6